EFFICIENCY OF INTEGRAL THERAPY AND POTENTIAL SIDE EFFECTS WHEN TREATING RESPIRATORY TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE

Abstract

Treatment of multiple drug resistant tuberculosis presents a serious challenge. Use of perchlozon (thioureidoiminomethylpyridini um) in the combination with the other five anti-tuberculosis drugs during 6 months of treatment allowed achieving cessation of bacillary excretion and X-ray improvement in all patients from the main group. Monitoring and evaluation of adverse events have not detected any confident difference in the number of adverse events apart from endocrine and allergic ones while taking perchlozon in the combination with other drugs. All adverse events were minor and moderate as regards severity degree and were managed by symptomatic treatment and did not cause cancellation of the drug. The obtained results will promote achieving the high tuberculosis treatment effciency by the end of the main chemotherapy course and this will require further investigation.

Keywords

• лечение туберкулеза
• множественная лекарственная устойчивостью возбудителя
• перхлозон (тиоуреидоиминометилпиридиния)